Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Name: (SPRING) Study of Pharmacodynamics and Relative Bioavailability of an Invented National Generic Enoxaparin

NCT07517289 is registered in ClinicalTrials.gov with Egyptian International Pharmaceutical Industries Co as lead sponsor.

NCT NCT07517289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07517289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Name: (SPRING) Study of Pharmacodynamics and Relative Bioavailability of an Invented National Generic Enoxaparin
Lead sponsor
Egyptian International Pharmaceutical Industries Co
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
August 31, 2026
Enrollment
26 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants study, the focus of the study is to determine the comparative pharmacodynamic of enoxaparin sodium with that of clexane in healthy human participants